Panlin Capital
Shanghai, Shanghaipanlincap.com
Overview
Panlin Capital is a Shanghai-based asset management firm that focuses on early stage investments in technology, healthcare, consumer goods, life science and retail related sectors across China . Panlin Capital targets start-ups specialized in biotechnology and data intelligence, following the investment theme of 'industrial upgrading driven by technology innovation' .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hangzhou LeadFlyte Technology Co., Ltd. | Feb 2026 | Series D | Co-investor |
| Aerofugia Technology Co., Ltd. | Feb 2026 | Series D | Co-investor |
| 成都海博为药业有限公司 | Oct 2025 | Series B | Co-investor |
| Shanghai UniXell Biotechnology | Apr 2025 | Series A | Co-investor |
| Bioyond Robotics | Oct 2024 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
